1st Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$102,300
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2010 $102,300 Replaced
1st Quarter - Amendment Apr 26, 2010 $142,363 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Senate, Labor HHS Appropriations; Senate HELP Committee; Senate Defense Appropriations; Senate Homeland Security & Government Affairs Committee; House Labor HHS Appropriations Subcommittee; House Homeland Security Committee. BARDA/HHS funding. BARDA funding/contract modification for anthrax rPA vaccine. Defense appropriations for funding of recombinant chemical nerve agent bioscavenger.

LobbyistCovered position, as disclosed
MARK EDWARD COOKE Sr. Director Government Affairs

Contacted: Homeland Security, Dept of (DHS); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.